These selected companies embody a new wave of technological advancement, each committed to solving critical challenges in heart and brain healthcare through novel methodologies and devices. The accelerator’s intent goes beyond traditional investment; it fosters a dynamic environment where innovation meets clinical expertise, ensuring that breakthroughs translate rapidly from concept to clinical application. The collaboration highlights AHA Ventures™ and Studio Red’s roles in not only funding but also mentoring startups, reinforcing a continuum from scientific research to market-ready healthcare solutions.

Among the cohort, Cerevia Neurosciences stands out with its development of a non-invasive, mobile, image-guided closed-loop neuromodulation platform. This device targets the restoration of cognitive function in dementia patients, leveraging neurotechnology to intervene in a traditionally challenging therapeutic area. Cerevia’s approach embodies a blend of advanced imaging and real-time neuromodulation, offering a scalable platform capable of continuous monitoring and adjustment, which could redefine treatment paradigms for neurodegenerative diseases.

Chambertech, a UK-based entity, is pioneering minimally invasive one-step hybrid ablation techniques specifically aimed at improving therapeutic outcomes in persistent atrial fibrillation—a major contributor to stroke risk. By integrating hybrid surgical and catheter-based ablation methods into a single minimally invasive procedure, Chambertech aims to enhance procedural efficacy and patient recovery times. This innovation targets a significant unmet need in cardiovascular electrophysiology, where current interventions often suffer from procedural complexity and variable success rates.

Envera Medical, another notable participant, is advancing neurovascular interventions with its novel balloon catheter designed for intracranial embolization procedures. These interventions are critical during the treatment of cerebral aneurysms and vascular malformations, where precision and safety are paramount. Envera’s device emphasizes ease of use and enhanced safety features, potentially reducing procedural risks and expanding treatment accessibility.

From the digital health sector, Eupnoos is breaking ground with non-invasive acoustic breath biomarkers for the early detection of cardiopulmonary alterations associated with heart failure and drug-induced lung injury. This technology harnesses advanced sound analysis to identify subtle respiratory changes, enabling remote monitoring and facilitating timely clinical responses. It exemplifies the growing convergence of digital biomarkers and telehealth, crucial for chronic disease management outside traditional clinical settings.

Flux Robotics offers an inventive solution through magnetically guided systems designed for the precise navigation of instruments within complex arterial pathways. This robotic-enhanced navigation reduces the mechanical challenges and risks inherent in maneuvering through tortuous vascular anatomies. By increasing procedural accuracy, Flux Robotics’ system promises to elevate the standard of care in endovascular interventions, potentially lowering complication rates and improving patient outcomes.

Lucentia’s software technology revolutionizes imaging diagnostics by transforming routine non-contrast CT scans into virtual coronary computed tomography angiography (CCTA). This innovation provides a non-invasive, accessible method for early heart disease detection, facilitating proactive patient management. The ability to derive detailed vascular imaging from standard CT scans could democratize cardiovascular assessment and reduce reliance on more invasive or costly diagnostic procedures.

OMINI introduces a portable platform capable of measuring multiple blood biomarkers simultaneously at the point of care, especially targeting the monitoring of chronic conditions such as heart failure. This approach aligns with the growing demand for real-time, multifactorial biomarker assessment in outpatient or home environments, enabling clinicians to track disease progression and therapeutic efficacy with unprecedented immediacy and detail.

Finally, Prima Medical contributes with an AI-driven real-time guidance system for pulsed field ablation catheters. This breakthrough integrates artificial intelligence into procedural workflows, enhancing the clinician’s ability to deliver precise therapy with immediate feedback. The fusion of AI and electrophysiological interventions represents a significant leap toward personalized and optimized treatment designs, advancing the frontier of catheter-based therapies.

The cohort was carefully curated by a committee comprising clinical investigators, investment strategists, and industry experts, ensuring that selected technologies demonstrate genuine innovation, clinical relevance, and potential for significant impact on patient care. As part of their involvement in the Heart and Brain Health Accelerator, these companies benefit from tailored mentorship and strategic support, focusing on navigating the complex landscape of cardiovascular and neurological health markets.

In addition to dedicated coaching, these innovators receive inclusion within the broader MedTech Innovator program for 2026. This extends their access to a robust network of industry leaders, funding opportunities, and heightened visibility in the medical technology ecosystem. This integration is further amplified by their qualification for the upcoming MedTech Innovator Competition Finals, scheduled for October 18–21, 2026, at the MedTech Conference in Boston, a premier platform for showcasing revolutionary healthcare technologies.

Crucially, the initiative introduces the inaugural MTI Index, a novel recognition system spotlighting the most promising medtech ventures. This index serves not only as a benchmark of innovation but also as a catalyst for accelerating commercialization and investment traction, accelerating the transition of innovative technologies from experimental stages to widespread clinical adoption.

This ambitious program showcases the American Heart Association’s commitment to catalyzing advancements across heart and brain health, leveraging venture capital expertise and clinical acumen to support solutions with the potential to save lives and improve quality of life globally. Through this initiative, the intersection of technology, medicine, and entrepreneurship is poised to deliver new hope to millions suffering from cardiovascular and neurological diseases worldwide.

Subject of Research: Cardiovascular and neurological health technology innovation through early-stage medical and digital health startups.

Article Title: American Heart Association and MedTech Innovator Launch 2026 Heart and Brain Health Accelerator to Propel Revolutionary Medical Technologies

News Publication Date: June 4, 2026

Web References:
– https://medtechinnovator.org/mti-aha-track/
– https://medtechinnovator.org/
– https://themedtechconference.com/
– https://newsroom.heart.org/news/startups-chosen-to-drive-technology-driven-improvements-in-womens-heart-and-brain-health

Keywords: Cardiovascular innovation, neurological health technology, medical device startups, neurotechnology, digital health biomarkers, catheter ablation, AI in medicine, non-invasive diagnostics, minimally invasive procedures, medtech acceleration, medical robotics, venture capital in health

The “Pace Me” platform ingeniously integrates a wearable activity tracker, specifically a Fitbit watch, with an intelligent mobile application that delivers timely, context-aware notifications throughout the day. These alerts serve as behavioral nudges, cautioning users before they potentially exceed their energy limits—a condition often exacerbating symptoms for those with Long COVID. This symbiotic wearable-app duo represents a novel approach by providing real-time feedback that empowers users to carefully balance activity and rest, mitigating episodes of symptom flare-ups.

Conceptualized and led by Dr. Lawrence Hayes from Lancaster University, along with Dr. Nilihan Sanal-Hayes and Professor Nicholas Sculthorpe, the trial stands as a beacon of multidisciplinary collaboration aimed at addressing the complex clinical challenge posed by Long COVID. The trial was meticulously designed, recruiting 250 participants who were randomized into two cohorts. The intervention group was equipped with the complete “Pace Me” system featuring active tracking and alert functionalities. In contrast, the control group used a version of the app restricted to data input screens, devoid of any tracking or proactive alerts, effectively serving as a placebo comparator.

What distinguishes this trial is its focus on PEM as a primary outcome measure—an intense exacerbation of symptoms following exertion, which notoriously hampers recovery in Long COVID sufferers. Over a span of six months, the study rigorously quantified both subjective symptom reports and objective wearable data. Although both cohorts exhibited symptomatic improvements, the digitally assisted intervention did not significantly outperform the control group in reducing PEM incidence overall. Remarkably, however, about 13 participants in the intervention arm transitioned from PEM-positive to PEM-negative status, with a notable 10% reduction in participants reporting PEM compared to baseline.

While the overall efficacy signal was modest, Dr. Hayes emphasizes that the safety profile and acceptability of the digital platform mark a vital milestone. The study validates the feasibility of deploying adaptive digital health tools for energy management in post-viral syndromes, an area historically underserved by conventional therapeutic strategies. This innovation opens the door for iterative refinement and targeted development that could cater to chronic conditions where symptom persistence and flare-ups predominate, such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), multiple sclerosis, and autoimmune diseases like lupus.

The trial’s methodological rigor lies in leveraging real-time physiological data to create personalized intervention thresholds, dynamically adjusting behavioral prompts in accordance with each user’s fluctuating capacity. This approach embodies a paradigm shift from static rehabilitation protocols to precision digital therapeutics, capable of delivering scalable and remotely accessible care solutions aligned with contemporary health system priorities. The design also highlights the importance of integrating user feedback loops within digital health ecosystems to optimize engagement and therapeutic adherence.

Importantly, the researchers contextualize their findings within broader health policy frameworks, referencing the NHS Long Term Plan and the Darzi report, both of which champion the digital transformation of healthcare delivery to improve chronic illness management. The platform’s adaptability signifies its potential for expansion beyond Long COVID to encompass diverse pathologies characterized by energy dysregulation and symptom exacerbation post-activity, thus presenting a versatile tool in the digital health arsenal.

Despite the lack of a statistically superior outcome relative to usual care, the learnings from this trial underscore critical considerations for future research. These include the need for refined algorithms that can better discriminate between safe and excessive activity levels, enhanced user interface designs to facilitate intuitive interaction, and integration with multidisciplinary care teams to provide holistic disease management. Emerging evidence from this study lays a vital foundation for subsequent trials exploring digital therapeutics in syndromes with overlapping pathophysiological and symptom profiles.

This investigation also calls attention to the nuanced trajectory of recovery in Long COVID compared to other chronic illnesses, advocating for digital tools that are tailored not only to individual patients but also to disease-specific progression patterns. Such precision aligns with the evolving paradigm of personalized medicine and underscores the necessity for multi-modal intervention strategies that incorporate physiological monitoring, symptom reporting, and psychosocial support within a unified platform.

In closing, the “Pace Me” digital tool heralds a promising frontier in the chronic disease management domain by harnessing wearable technology and real-time analytics to empower patients in self-regulating their activity. While further technological enhancement and clinical validation are warranted, this pioneering study delineates a compelling framework for leveraging digital platforms to ameliorate the burdens of Long COVID and potentially other fatiguing conditions that challenge conventional treatment paradigms.

Subject of Research: People

Article Title: A Digital Platform with Activity Tracking for Energy Management Support in Long COVID: A Randomised Controlled Trial

News Publication Date: 2-Feb-2026

Web References: http://dx.doi.org/10.1038/s41467-025-64831-y

Image Credits: Lancaster University

Keywords: Long COVID, Human health, Chronic fatigue syndrome, Information technology, Smartphones, Health care, Health care delivery

Pressure injuries, commonly known as bedsores or pressure ulcers, arise from prolonged pressure on the skin and underlying tissues. These injuries can lead to complications such as infections, increased hospital stays, and diminished quality of life for patients. The need for effective care strategies is critical, especially for vulnerable populations, including the elderly and those with mobility issues. Traditional care methods have often been inadequate, prompting researchers to explore innovative technological solutions to drive improvement.

The MDeCC prototype stands out due to its user-centric design, which leverages multidisciplinary expertise to enhance patient outcomes. By integrating various healthcare professionals, including nurses, physicians, and therapists, the tool fosters a more inclusive care environment. The development process involved comprehensive research, guided by the principles of collaboration and patient-centered care, ensuring that all professionals contribute their specialized knowledge to address the complex needs of patients with pressure injuries.

One of the critical aspects of the MDeCC prototype is its advanced digital platform enabling real-time communication among various healthcare providers. This capability holds immense potential to streamline care processes, reduce redundancies, and enhance decision-making. In an environment where timely intervention is crucial, particularly for patients at risk of developing pressure injuries, the ability to share information instantly can make a significant difference.

Moreover, the MDeCC prototype incorporates data analytics tools to monitor patient progress continuously. By analyzing parameters such as skin integrity, wound healing stages, and patient mobility, healthcare providers can identify trends and make informed decisions regarding interventions or necessary adjustments in treatment plans. This data-driven approach epitomizes the future of healthcare, where technology plays a pivotal role in facilitating better patient outcomes.

The design of the MDeCC prototype is also influenced by feedback from end-users, particularly the healthcare professionals who will utilize it in their practice. Engaging these individuals throughout the development process has been key to ensuring that the tool is not only functional but also intuitive and easy to navigate. An e-Care application that is cumbersome or difficult to use can hinder its effectiveness, making user experience a top priority.

The implementation of the MDeCC prototype can potentially revolutionize how pressure injuries are managed in clinical settings. In acute care facilities, for example, where patient turnover is high, healthcare staff must quickly identify and address risks associated with pressure injuries. The MDeCC’s coordination capabilities can ensure that critical information flows seamlessly between departments, leaving no room for oversight that could lead to adverse patient outcomes.

In addition to its practical implications, the MDeCC prototype presents exciting opportunities for research. As data is collected and analyzed, researchers can gain valuable insights into the patterns and predictors of pressure injuries. This knowledge can inform future clinical guidelines and best practices, paving the way for enhanced healthcare protocols that specifically target the prevention and management of these injuries.

Collaboration beyond clinical settings is also a feature of the MDeCC initiative. By incorporating insights from various stakeholders, including patients, caregivers, and health systems, the program aims to foster a holistic understanding of pressure injury management. Patient engagement in research not only aids in understanding practical challenges faced on the ground but also ensures that the solutions developed address real-world needs.

The implementation of such an e-Care tool, however, does not come without challenges. Issues regarding data security, privacy, and interoperability among existing health records are vital considerations that must be addressed to ensure the MDeCC prototype’s success. As healthcare increasingly embraces digital transformation, navigating these hurdles will be crucial to fostering trust and acceptance among users.

Furthermore, an essential component of this initiative involves training healthcare providers on effectively using the MDeCC prototype. An investment in education is vital to ensure that all involved parties are equipped with the knowledge required to leverage the platform optimally. As technology continues to evolve, maintaining a well-trained workforce remains a cornerstone of successful implementation.

In conclusion, as the healthcare industry grapples with the complexities of managing pressure injuries, the MDeCC prototype emerges as a beacon of hope. By fostering collaboration across disciplines, enhancing communication, and utilizing innovative technology, it presents a comprehensive solution that is poised to improve patient outcomes significantly. The future of healthcare is undoubtedly intertwined with such digital innovations, which serve to empower both providers and patients to achieve better health and quality of life.

The journey of the MDeCC prototype signifies the ongoing evolution and integration of technology into every aspect of healthcare practice. Researchers and healthcare professionals alike are optimistic about the potential impact this tool will have on patient care. As we move forward, it will be exciting to observe how the lessons learned from this prototype can shape forthcoming innovations and practices in the healthcare ecosystem.

As the MDeCC continues to be developed and fine-tuned, its potential applications could extend beyond pressure injuries to other areas of patient care, highlighting the versatility of interdisciplinary approaches. With a commitment to continual improvement and adaptation, the pathway is clear for this prototype to make a meaningful difference in the world of healthcare.

Overall, the Multidisciplinary e-Care Coordination prototype represents a significant advancement in the way pressure injuries are addressed within healthcare settings. By integrating technology, multidisciplinary cooperation, and patient-centered strategies, this innovative tool has the potential to reshape how these injuries are managed in a healthcare landscape that increasingly demands efficiency and effectiveness.

With promising findings on the horizon, the health community should keep a close eye on the outcomes generated by the MDeCC initiative. The combination of clinical expertise and technological innovation stands to revolutionize not just pressure injury management, but potentially other aspects of patient care in the future.

Subject of Research: Multidisciplinary e-Care Coordination for pressure injuries management

Article Title: The development of a Multidisciplinary e-Care Coordination (MDeCC) prototype to facilitate effective care of pressure injuries.

Article References:

Al-Moteri, M., Sahrah, A.Z., Althobiti, E.S. et al. The development of a Multidisciplinary e-Care Coordination (MDeCC) prototype to facilitate effective care of pressure injuries. BMC Health Serv Res 25, 1434 (2025). https://doi.org/10.1186/s12913-025-13587-8

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12913-025-13587-8

Keywords: pressure injuries, e-Care, healthcare innovation, multidisciplinary collaboration, patient care.

Social determinants of health, encompassing factors like food insecurity, housing instability, and transportation barriers, have long been recognized as critical contributors to health outcomes. Despite this, interventions to address these factors have often faced challenges due to resource intensity and operational complexity. Historically, programs aiming to connect families with social services have depended heavily on in-person social work or intensive case management, creating scalability barriers. The University of Chicago Medicine study disrupts this paradigm by demonstrating that digital prescription of community resources, coupled with automated follow-up, can achieve comparable reductions in acute care use with a fraction of resources.

The trial enrolled 640 parents and primary caregivers of hospitalized children across three years, randomly dividing participants into two groups: usual discharge procedures and an intervention group receiving a tailored “HealtheRx” — a printout customized to list local food pantries, rental assistance programs, transportation services, and other vital community resources. Uniquely, this intervention was universally delivered regardless of whether families initially screened positive for social needs, embracing the reality that social risk fluctuates over time and may emerge unexpectedly, such as during a child’s hospitalization.

Following discharge, caregivers in the intervention arm were enrolled in a three-month automated texting program delivering periodic reminders and fresh resource links. Importantly, caregivers were empowered to respond to texts, triggering personalized assistance from trained navigators throughout the subsequent year. This combination of technology and human touch provided scalable yet responsive support, ensuring that families could access additional help as their circumstances evolved without requiring staff-intensive direct outreach to all participants.

A critical aspect of this research was its double-blind design, making it the first of its kind in social care intervention studies. Neither families nor research staff knew which group received the HealtheRx intervention versus standard care, removing bias and providing gold-standard evidence for the effectiveness of this approach. This rigor lends substantial credibility to the findings, countering critiques that social care interventions lack sufficient methodological robustness.

The impact observed among food-insecure families was striking. At three months post-discharge, 69% of caregivers who received the intervention rated their child’s health as “excellent or very good,” compared with only 45% in the standard care group. More impressively, one year after intervention delivery, only 30% of children from food-insecure households in the intervention group visited the emergency department, compared to 52% among controls. Hospital readmissions trended downward as well, particularly for those families who proactively requested further resource information.

Comparatively, previous social resource interventions required as much as five hours of staff time per family, often involving home visits and direct appointments. In stark contrast, the CommunityRx-Hunger program studied here demanded approximately 50 total staff hours for the entire intervention cohort, highlighting its unprecedented efficiency. This reduction in human effort makes the model highly attractive to healthcare systems seeking scalable interventions amid growing pressures for cost containment and improved population health outcomes.

In estimating the economic implications, researchers applied national averages for pediatric emergency and inpatient costs, revealing an estimated $3,000 saved per food-insecure child over one year. These savings easily offset the technological costs related to automated messaging and navigator support, illustrating that strategic social care integration not only benefits patient well-being but also offers compelling value to healthcare payers and providers.

The study’s timing is especially pertinent given recent regulatory shifts. The U.S. Centers for Medicare and Medicaid Services recently proposed removing hospital directives requiring screening for social drivers of health. In the absence of mandated screening, universally-applicable interventions like CommunityRx-Hunger provide a vital pathway to address social needs without the risk of missing families who do not screen positive but still experience acute vulnerabilities. This universality also accommodates the dynamic nature of social risk, as families frequently transition in and out of precarious situations.

Notably, even among families initially classified as food secure, one-third sought additional assistance through the intervention, sometimes for urgent concerns such as mental health crises, safety issues, or emergency housing. This finding powerfully illustrates that social conditions are not static traits but ever-changing states influenced by circumstances, including the stress and disruption caused by a child’s hospitalization. Delivering social care universally thus ensures broader reach and equity in service delivery.

Moreover, the HealtheRx intervention extends its impact beyond individual recipients through community ripple effects. Past data from the broader CommunityRx program have demonstrated that over half of participants shared resource information with others, amplifying benefits across social networks and enhancing community resilience. This diffusion suggests that scalable, digitally-enabled social prescribing models can transform not only individual health trajectories but also strengthen support ecosystems.

From a practical standpoint, many U.S. health systems already license community-resource referral platforms and integrate texting tools, making replication of CommunityRx-Hunger highly feasible. Institutionalizing such low-intensity social care interventions within standard pediatric discharge protocols could soon become an integral component of holistic healthcare. Forward-looking hospitals may routinely complement traditional prescriptions and appointments with tailored resource lists and automated outreach, ushering in an era of socially informed medicine that proactively addresses upstream determinants of health.

This landmark study establishes compelling evidence that leveraging technology and community partnerships to uniformly “prescribe” social resources to families during pediatric hospital discharge is an effective, cost-saving strategy to reduce acute healthcare utilization. Its innovative design and striking outcomes highlight a scalable model with transformative potential for pediatric healthcare delivery — one that acknowledges the inseparability of social context and health and mobilizes simple, accessible tools to improve outcomes at scale. As hospitals nationwide grapple with rising costs and complex patient needs, integrating such low-intensity social care interventions may be key to healthier children, less stressed caregivers, and more sustainable health systems.

Subject of Research: People
Article Title: Low-Intensity Social Care and Child Acute Health Care Utilization: A Randomized Clinical Trial
News Publication Date: 28-Apr-2025
Web References:

• https://jamanetwork.com/journals/jama/fullarticle/10.1001/jamapediatrics.2025.0484
• https://www.uchicagomedicine.org/forefront/prevention-and-screening-articles/uchicagos-communityrx-intervention-helps-patients-find-community-resources
• https://www.cms.gov/newsroom/fact-sheets/fy-2026-hospital-inpatient-prospective-payment-system-ipps-and-long-term-care-hospital-prospective
• https://www.healthaffairs.org/doi/10.1377/hlthaff.2016.0694
  References: 10.1001/jamapediatrics.2025.0484
  Keywords: Emergency medicine, Food security